ASEAN Cosmetic Directive

Also known as: ACD · ASEAN Harmonized Cosmetic Regulatory Scheme (the umbrella agreement containing the ACD) · AHCRS · ASEAN Cosmetic Directive of 2 September 2003

Aesthetics

Definition

The ASEAN Cosmetic Directive (ACD) is the harmonized framework regulating cosmetic products among the member states of the Association of Southeast Asian Nations (ASEAN). It was adopted as an integral component of the Agreement on the ASEAN Harmonized Cosmetic Regulatory Scheme (AHCRS), signed by ASEAN economic ministers at the 35th ASEAN Economic Ministers Meeting on 2 September 2003 in Phnom Penh. The AHCRS comprises two instruments: the ASEAN Mutual Recognition Arrangement of Product Registration Approvals for Cosmetics and the ASEAN Cosmetic Directive itself, which aligns member states’ requirements for cosmetic safety, ingredients, and labeling and replaces divergent pre-market registration regimes with a notification-based system backed by post-market surveillance. (ASEAN agreements database, ASEAN Cosmetics Association — History)

Modeled broadly on the European Union’s Cosmetics Directive, the ACD assigns responsibility for product safety to the company placing the cosmetic on the market, requires ingredient compliance with common annexes of banned and restricted substances, and governs claims through the ASEAN Cosmetic Claim guidelines. The Philippines implemented the scheme through Department of Health Administrative Order No. 2005-0015, issued in 2005, which adopted the AHCRS and the ASEAN Common Technical Documents into national regulation and tasked the Bureau of Food and Drugs — now the Food and Drug Administration (FDA), whose modern statutory authority rests on Republic Act No. 9711 — with administration of cosmetic notifications. (ASEAN Cosmetics Association — History, Supreme Court E-Library — DOH AO 2005-0015, Health Sciences Authority of Singapore)

Identities

Source Type	Identity
Wikipedia	N/A
Wikidata	N/A
DBpedia	N/A
ProductOntology	N/A
Wiktionary	N/A
Library of Congress Subject Headings (LCSH)	N/A
MeSH	N/A
NCBI Taxonomy	N/A
AGROVOC	N/A
Google Scholar	“ASEAN Cosmetic Directive” harmonized regulatory scheme Philippines notification
ConceptNet	N/A
OpenCyc	N/A

Also Known As

ACD
ASEAN Harmonized Cosmetic Regulatory Scheme (the umbrella agreement containing the ACD)
AHCRS
ASEAN Cosmetic Directive of 2 September 2003

Examples and Analogies

Statutory analog: the ACD stands to ASEAN cosmetics regulation as the EU Cosmetics Directive 76/768/EEC stood to the European single market — a harmonizing instrument that replaced ten (now eleven) national regimes with one set of definitions, ingredient lists, and labeling rules, shifting control from pre-market approval to company responsibility with post-market oversight. (Wikipedia — Cosmetics Directive)
Analog for the notification system: where the old regime worked like a driver’s license exam (the regulator tests and approves before you may operate), the ACD works like vehicle registration (the company notifies, assumes responsibility, and faces inspection and sanctions after the fact).
Verified data:
Umbrella agreement: Agreement on the ASEAN Harmonized Cosmetic Regulatory Scheme, signed 2 September 2003 at the 35th ASEAN Economic Ministers Meeting
Two components: ASEAN Mutual Recognition Arrangement of Product Registration Approvals for Cosmetics; ASEAN Cosmetic Directive
Preparatory work: ASEAN cosmetic regulators and industry had collaborated since 1998 through the Cosmetic Product Working Group under the ASEAN Consultative Committee for Standards and Quality
Philippine implementation: DOH Administrative Order No. 2005-0015 (2005), administered by BFAD, now the FDA
Claims instrument: ASEAN Cosmetic Claim guidelines (Appendix III of the ACD)
Maintaining body: the ASEAN Cosmetic Committee, whose adopted amendments are incorporated into Philippine law through FDA circulars

Usage Scenarios

1. Cosmetic Product Notification in the Philippines

Before placing a cosmetic product on the Philippine market, a company holding an FDA License to Operate files a product notification, and the FDA issues a Certificate of Product Notification. The notified product must comply with the ACD, its annexes, and appendices — the operative compliance pathway for everything from skincare to makeup sold in the country. (ChemLinked — Philippines cosmetic regulation)

2. Ingredient Compliance

Formulators check ACD annexes — the lists of substances banned or restricted in cosmetics, together with positive lists such as permitted colorants — which the FDA enforces in the Philippines and which are periodically amended by decisions of the ASEAN Cosmetic Committee. (Health Sciences Authority of Singapore, FDA Circular No. 2026-0001)

3. Cosmetic Claims Management

Claims on labels and advertising are screened against the ASEAN Cosmetic Claim guidelines, which confine claims to cosmetic effects and bar medicinal or therapeutic representations, with a common decision process for identifying whether a product is a cosmetic at all. (ASEAN Cosmetics Association — History)

4. Regional Trade Facilitation

The Mutual Recognition Arrangement and the harmonized scheme reduce duplicate requirements, allowing a cosmetic company to design one compliant formulation, dossier, and label architecture for multiple ASEAN markets — the core economic rationale of the directive. (ASEAN Cosmetics Association — History)

5. Post-Market Surveillance and Enforcement

Because the ACD substitutes surveillance for pre-market approval, the FDA monitors marketed cosmetics, issues public advisories against unsafe or mislabeled products, and adopts consolidated ACD amendments through circulars — such as the circular consolidating amendments adopted at the 40th to 42nd ASEAN Cosmetic Committee meetings. (FDA Circular No. 2026-0001)

Strategies

Harmonize-instead-of-register: the ACD eliminated country-by-country pre-market registration in favor of a common definition of cosmetics, shared ingredient lists, and notification, lowering barriers to intra-ASEAN trade. (ASEAN Cosmetics Association — History)
Co-regulation with industry: the scheme was built from 1998 onward by regulators and industry working together through the Cosmetic Product Working Group, producing technical documents that made implementation practical. (ASEAN Cosmetics Association — History)
Company responsibility model: safety assessment, product information retention, and claims substantiation sit with the marketing company, reserving regulator capacity for surveillance and enforcement.
Amendment by committee: the ASEAN Cosmetic Committee updates the annexes as science evolves, and national regulators (the FDA in the Philippines) fold those amendments into domestic rules through circulars. (FDA Circular No. 2026-0001)
Staged national adoption: the 2003 agreement allowed member states to legislate implementation on their own timetables, with regulators such as Singapore’s HSA bringing the directive into force from January 2008. (Health Sciences Authority of Singapore)

Security and Safety Measures

Ingredient annexes: banned and restricted substance lists and positive lists of colorants are enforced across member states, creating a common floor of chemical safety. (Health Sciences Authority of Singapore)
Notification and traceability: every marketed product is notified to the national regulator, creating a registry that enables targeted recalls and advisories. (ChemLinked — Philippines cosmetic regulation)
Claims discipline: the ASEAN Cosmetic Claim guidelines bar therapeutic claims that would push a product into drug regulation, protecting consumers from misleading efficacy representations. (ASEAN Cosmetics Association — History)
Post-market surveillance: regulators conduct market monitoring, laboratory testing, and public warnings, backed in the Philippines by the enforcement powers of the FDA under RA 9711. (FDA Circular No. 2026-0001)
Product information retention: companies must maintain the technical dossier supporting each notified product, available for regulatory inspection.

Historical Context

Harmonization of cosmetic regulation in Southeast Asia began well before the directive itself: since 1998, ASEAN cosmetic regulators and industry representatives had worked through the Cosmetic Product Working Group under the ASEAN Consultative Committee for Standards and Quality to remove trade barriers in the sector. That preparatory work culminated in the Agreement on the ASEAN Harmonized Cosmetic Regulatory Scheme, signed on 2 September 2003 at the 35th ASEAN Economic Ministers Meeting, whose two components — the Mutual Recognition Arrangement and the ASEAN Cosmetic Directive — created a single regulatory architecture for the region’s cosmetics market. (ASEAN Cosmetics Association — History, ASEAN agreements database)

The Philippines moved early to domesticate the scheme. In 2005 the Department of Health issued Administrative Order No. 2005-0015, adopting the AHCRS and the ASEAN Common Technical Documents and shifting Philippine cosmetics regulation from pre-market registration to a notification system with post-market surveillance, administered by the Bureau of Food and Drugs. When RA 9711 converted BFAD into the strengthened Food and Drug Administration in 2009, the agency retained and expanded this ASEAN-aligned role, and the FDA’s implementation has been assessed academically as among the most efficient e-notification systems in the region. The ASEAN Cosmetic Committee continues to amend the directive’s annexes, and the FDA incorporates those amendments into Philippine law through circulars. (Supreme Court E-Library — DOH AO 2005-0015, ChemLinked — Philippines cosmetic regulation, UP Open University repository)

Challenges and Controversies

Compliance Burden on Small Producers

The ACD simplifies trade for large multinational formulators, but Philippine micro, small, and medium enterprises still face the fixed costs of the regime — an FDA License to Operate, per-product notifications, Product Information File documentation, and compliant labeling — obligations that industry studies of the scheme and its implementation have examined in depth. Academics at the University of the Philippines Open University have assessed the scheme’s benefits, outcomes, and impact, a research agenda that itself reflects continuing debate over whether harmonized regulation serves smaller industry players as well as it serves regional trade. (UP Open University repository, ChemLinked — Philippines cosmetic regulation)

Cosmetic–Medicinal Claim Boundary

Because the ACD confines cosmetics to non-therapeutic claims, products marketed with drug-like promises — whitening, anti-aging, and treatment claims — test the boundary between cosmetic notification and drug registration. Enforcement against misclassified products absorbs significant regulatory attention under the post-market model. (ASEAN Cosmetics Association — History)

Keeping Pace with Amendments

The directive’s annexes change frequently through ASEAN Cosmetic Committee decisions, and companies must track consolidated amendments — such as those from the 40th to 42nd Committee meetings adopted by the FDA in a single circular — creating a moving compliance target for firms with long product cycles. (FDA Circular No. 2026-0001)

Uneven Implementation Across Member States

Although the scheme is regional, implementation is national: each member state brought the ACD into force on its own schedule and with its own administrative machinery, so compliance in one market does not perfectly predict treatment in another — a limitation acknowledged in sector assessments of the scheme. (UP Open University repository, Health Sciences Authority of Singapore)